AUCTA PHARMACEUTICALS
Live / Registered — Registered (as of 17 Feb 2026)
What this means for you
Registered since 17 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97276478
- Registration number
- 8145708
- Mark type
- Stylized text
- Filed
- 21 Feb 2022
- Published for opposition
- 01 Nov 2022
- Registered
- 17 Feb 2026
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; Pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression
Owner
- Aucta Pharmaceuticals, Inc., Piscataway, NJ, US
- Aucta Pharmaceuticals, Inc., Piscataway, NJ, US
- Aucta Pharmaceuticals, Inc., Piscataway, NJ, US
Prosecution history
- 17 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 26 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Dec 2025 — USE AMENDMENT FILED
- 23 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2025 — SOU EXTENSION 5 GRANTED
- 04 Jun 2025 — SOU EXTENSION 5 FILED
- 04 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2024 — SOU EXTENSION 4 GRANTED
- 05 Dec 2024 — SOU EXTENSION 4 FILED